Suppr超能文献

分析缺血性心脏中间充质干细胞的蛋白质组

Analysis of mesenchymal stem cell proteomes in the ischemic heart.

机构信息

Department of Biomedical Engineering, University of Alabama at Birmingham, School of Medicine and School of Engineering, Birmingham, AL 35294, USA.

Department of Cardiology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China.

出版信息

Theranostics. 2020 Sep 14;10(24):11324-11338. doi: 10.7150/thno.47893. eCollection 2020.

Abstract

Cell therapy for myocardial infarction is promising but largely unsuccessful in part due to a lack of mechanistic understanding. Techniques enabling identification of stem cell-specific proteomes in the injured heart may shed light on how the administered cells respond to the injured microenvironment and exert reparative effects. To identify the proteomes of the transplanted mesenchymal stem cells (MSCs) in the infarcted myocardium, we sought to target a mutant methionyl-tRNA synthetase (MetRS) in MSCs, which charges azidonorleucine (ANL), a methionine analogue and non-canonical amino acid, to tRNA and subsequently to nascent proteins, permitting isolation of ANL-labeled MSC proteomes from ischemic hearts by ANL-alkyne based click reaction. Murine MSCs were transduced with lentivirus MetRS and supplemented with ANL; the ANL-tagged nascent proteins were visualized by bio-orthogonal non-canonical amino-acid tagging, spanning all molecular weights and by fluorescent non-canonical amino-acid tagging, displaying strong fluorescent signal. Then, the MetRS-transduced MSCs were administered to the infarcted or Sham heart in mice receiving ANL treatment. The MSC proteomes were isolated from the left ventricular protein lysates by click reaction at days 1, 3, and 7 after cell administration, identified by LC/MS. Among all identified proteins (in Sham and MI hearts, three time-points each), 648 were shared by all 6 groups, accounting for 82±5% of total proteins in each group, and enriched under mitochondrion, extracellular exosomes, oxidation-reduction process and poly(A) RNA binding. Notably, 26, 110 and 65 proteins were significantly up-regulated and 11, 28 and 19 proteins were down-regulated in the infarcted vs. Sham heart at the three time-points, respectively; these proteins are pronounced in the GO terms of extracellular matrix organization, response to stress and regulation of apoptotic process and in the KEGG pathways of complements and coagulation cascades, apoptosis, and regulators of actin cytoskeleton. MetRS expression allows successful identification of MSC-specific nascent proteins in the infarcted hearts, which reflect the functional states, adaptive response, and reparative effects of MSCs that may be leveraged to improve cardiac repair.

摘要

细胞疗法治疗心肌梗死有很大的应用前景,但在很大程度上并不成功,部分原因是缺乏对其机制的了解。能够识别受损心脏中干细胞特异性蛋白质组的技术,可能有助于阐明给予的细胞如何对受损的微环境做出反应并发挥修复作用。为了鉴定移植到梗死心肌中的间充质干细胞(MSCs)的蛋白质组,我们试图靶向 MSC 中的突变甲硫氨酰-tRNA 合成酶(MetRS),该酶将叠氮正亮氨酸(ANL),一种甲硫氨酸类似物和非典型氨基酸,加载到 tRNA 上,然后加载到新生蛋白质上,通过基于炔基-叠氮化物点击反应,从缺血心脏中分离出 ANL 标记的 MSC 蛋白质组。用慢病毒 MetRS 转导鼠 MSCs,并补充 ANL;通过生物正交非典型氨基酸标记,跨越所有分子量和荧光非典型氨基酸标记,显示出强荧光信号,来可视化 ANL 标记的新生蛋白。然后,将 MetRS 转导的 MSC 给予接受 ANL 治疗的梗死或假手术心脏的小鼠。通过点击反应,在细胞给药后第 1、3 和 7 天,从左心室蛋白裂解物中分离 MSC 蛋白质组,然后通过 LC/MS 进行鉴定。在所有鉴定的蛋白质(假手术和 MI 心脏,每个时间点 3 个)中,有 648 个存在于所有 6 个组中,占每个组中总蛋白质的 82±5%,并且在细胞器、细胞外外泌体、氧化还原过程和多(A)RNA 结合中富集。值得注意的是,在 3 个时间点,与假手术心脏相比,梗死心脏中有 26、110 和 65 个蛋白质显著上调,而 11、28 和 19 个蛋白质下调;这些蛋白质在细胞外基质组织、应激反应和细胞凋亡过程的调节以及补体和凝血级联、细胞凋亡和肌动蛋白细胞骨架调节的关键基因通路中明显上调。MetRS 表达允许成功鉴定出在梗死心脏中的 MSC 特异性新生蛋白质,这些蛋白质反映了 MSC 的功能状态、适应反应和修复作用,可能有助于改善心脏修复。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b72/7532665/61b8c9eeb73b/thnov10p11324g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验